Cargando…

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation

We report on a 32-year old female patient with primary antiphospholipid syndrome (PAPS) and several thromboembolic events despite stable doses of oral anticoagulation, good patient compliance and maintained INR values of >3. Over the preceding 3 years the patient had presented a wide spectrum of...

Descripción completa

Detalles Bibliográficos
Autores principales: Miesbach, W., Scharrer, I., Asherson, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102000/
https://www.ncbi.nlm.nih.gov/pubmed/15168158
http://dx.doi.org/10.1007/s10067-004-0864-0
_version_ 1783511733771436032
author Miesbach, W.
Scharrer, I.
Asherson, R. A.
author_facet Miesbach, W.
Scharrer, I.
Asherson, R. A.
author_sort Miesbach, W.
collection PubMed
description We report on a 32-year old female patient with primary antiphospholipid syndrome (PAPS) and several thromboembolic events despite stable doses of oral anticoagulation, good patient compliance and maintained INR values of >3. Over the preceding 3 years the patient had presented a wide spectrum of manifestations of APS, including recurrent venous and arterial thromboses, cardiac, gynecological (HELLP syndrome), neurological involvements, livedo reticularis, a mild thrombocytopenia and the most feared manifestation of the catastrophic antiphospholipid syndrome (CAPS). Life-threatening bilateral subdural bleeding occurred while she was anticoagulated. The clinical features appeared to be refractory to oral anticoagulation with phenprocoumon. They were life threatening on each occasion and she developed repetitive episodes of organ damage with cardiac insufficiency (NYHA III), pulmonary hypertension and other residual defects. Even during heparinization recurrent thromboembolism supervened as well as livedo reticularis of the extremities. Lupus anticoagulants (LAC), anticardiolipin (aCL) antibodies and anti-β(2)-glycoprotein-1 (β(2)GPI) titers were all markedly elevated. This case report shows that recurrent episodes of thrombosis can occur despite seemingly adequate anticoagulation in patients with CAPS.
format Online
Article
Text
id pubmed-7102000
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-71020002020-03-31 Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation Miesbach, W. Scharrer, I. Asherson, R. A. Clin Rheumatol Case Report We report on a 32-year old female patient with primary antiphospholipid syndrome (PAPS) and several thromboembolic events despite stable doses of oral anticoagulation, good patient compliance and maintained INR values of >3. Over the preceding 3 years the patient had presented a wide spectrum of manifestations of APS, including recurrent venous and arterial thromboses, cardiac, gynecological (HELLP syndrome), neurological involvements, livedo reticularis, a mild thrombocytopenia and the most feared manifestation of the catastrophic antiphospholipid syndrome (CAPS). Life-threatening bilateral subdural bleeding occurred while she was anticoagulated. The clinical features appeared to be refractory to oral anticoagulation with phenprocoumon. They were life threatening on each occasion and she developed repetitive episodes of organ damage with cardiac insufficiency (NYHA III), pulmonary hypertension and other residual defects. Even during heparinization recurrent thromboembolism supervened as well as livedo reticularis of the extremities. Lupus anticoagulants (LAC), anticardiolipin (aCL) antibodies and anti-β(2)-glycoprotein-1 (β(2)GPI) titers were all markedly elevated. This case report shows that recurrent episodes of thrombosis can occur despite seemingly adequate anticoagulation in patients with CAPS. Springer-Verlag 2004-03-20 2004 /pmc/articles/PMC7102000/ /pubmed/15168158 http://dx.doi.org/10.1007/s10067-004-0864-0 Text en © Clinical Rheumatology 2004 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Miesbach, W.
Scharrer, I.
Asherson, R. A.
Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
title Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
title_full Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
title_fullStr Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
title_full_unstemmed Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
title_short Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
title_sort recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102000/
https://www.ncbi.nlm.nih.gov/pubmed/15168158
http://dx.doi.org/10.1007/s10067-004-0864-0
work_keys_str_mv AT miesbachw recurrentlifethreateningthromboembolismandcatastrophicantiphospholipidsyndromeinapatientdespitesufficientoralanticoagulation
AT scharreri recurrentlifethreateningthromboembolismandcatastrophicantiphospholipidsyndromeinapatientdespitesufficientoralanticoagulation
AT ashersonra recurrentlifethreateningthromboembolismandcatastrophicantiphospholipidsyndromeinapatientdespitesufficientoralanticoagulation